Healthcare -
Biotechnology - NASDAQ - GB
$ 10.72
-2.28 %
$ 740 M
Market Cap
-3.7
P/E
BCYC - COST OF REVENUE
Cost of Revenue BCYC - Bicycle Therapeutics plc
6.47 M
LAST VALUE
-62.04%
2 YEAR CAGR
-20.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR